Premium
Daratumumab proves safe and highly effective in AL amyloidosis
Author(s) -
Khouri Jack,
Kin Andrew,
Thapa Bicky,
Reu Frederic J.,
Bumma Naresh,
Samaras Christy J.,
Liu Hien D.,
Karam Mary A.,
Reed Janice,
Mathur Saveta,
Faiman Beth M.,
Devries Georgia,
Zonder Jeffrey,
Valent Jason
Publication year - 2019
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.15455
Subject(s) - daratumumab , medicine , al amyloidosis , tolerability , proteasome inhibitor , gastroenterology , multiple myeloma , oncology , adverse effect , immunology , bortezomib , antibody , immunoglobulin light chain